Long-acting analog of human insulin produced by recombinant DNA technology. Prepn: M. Drschug, DE 3837825; idem, US 5656722 (1990, 1997 both to Hoechst). Characterization of receptor interaction: L. Berti et al., Horm. Metab. Res. 30, 123 (1998). Clinical pharmacodynamics: L. Heinemann et al., Diabetes Care 23, 644 (2000); pharmacokinetics: D. R. Owens et al., ibid. 813. Clinical trial in type 1 diabetics: R. E. Ratner et al., ibid. 639. Review of clinical experience: P. S. Gillies et al., Drugs 59, 253-260 (2000).
Antidiabetic.
Antidiabetic; Hormones/Analogs